Preparation and In-Vitro Biocompatibility of Gelatin/Sa/Hya Composite Scaffold for Tissue Engineering
Source abstract
Abstract
Novel gelatin/sodium alginate (SA) porous scaffolds containing hyaluronic acid (HYA) were fabricated via freeze-drying technique and their in-vitro biocompatibility was investigated. It was demonstrated that the gelatin/ SA/HYA composite scaffolds had highly homogeneous and interconnected pores with average pore size ranging from 50 to 400 μm. The extracts of gelatin/SA/HYA with various contents of 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide (EDC) showed no toxicity due to easy removal of excess EDC. Fibroblastic cells attached to the culture plate and showed normal morphology when cultured in the extract of gelatin/SA/HYA hydrogel. The introduction of HYA into the gelatin/SA matrix facilitated the adhesion of fibroblasts in the gelatin/SA/HYA scaffolds. The haemolytic test indicated that the gelatin/SA/HYA composite hydrogel showed no haemolysis. Therefore, the gelatin/SA/HYA composite scaffolds would be suitable for cell adhesion and growth and could offer new and important options for tissue engineering applications.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Changsha Environmental Protection College, Changsha, P.R. China
References (27)
Show source-provided references
1. 10.1016/j.biomaterials.2005.02.00210.1016/j.biomaterials.2005.02.002 ↗
2. 10.1016/S0142-9612(03)00339-910.1016/S0142-9612(03)00339-9 ↗
3. 10.1088/1748-6041/4/5/05500810.1088/1748-6041/4/5/055008 ↗
4. 10.1080/03602559.2012.71840010.1080/03602559.2012.718400 ↗
5. 10.1080/00914037.2011.61007010.1080/00914037.2011.610070 ↗
6. 10.1080/03602559.2013.79881810.1080/03602559.2013.798818 ↗
7. KuoC.K., MaP.X. J. Biomed. Mater. Res. A, 90, (2007) 899–907.
8. RoselliniE., CristalliniC., BarbaniN., VozziG., GoustiP. J. Biomed. Mater. Res. A, 91, (2008) 447–453.
9. 10.1080/00914037.2012.71086210.1080/00914037.2012.710862 ↗
10. 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W ↗
11. 10.1080/00222348.2011.56280710.1080/00222348.2011.562807 ↗
12. 10.1080/03602559.2011.63983010.1080/03602559.2011.639830 ↗
13. 10.1080/03602559.2012.66303710.1080/03602559.2012.663037 ↗
14. 10.1163/15685620432275221910.1163/156856204322752219 ↗
15. 10.1177/09673911120200090410.1177/096739111202000904 ↗
16. 10.1046/j.1524-475X.1999.00079.x10.1046/j.1524-475X.1999.00079.x ↗
17. 10.2165/00128071-200506060-0000610.2165/00128071-200506060-00006 ↗
18. 10.1016/j.biomaterials.2010.12.02410.1016/j.biomaterials.2010.12.024 ↗
19. 10.1002/jbm.a.3097410.1002/jbm.a.30974 ↗
20. 10.1080/10601325.2013.82936010.1080/10601325.2013.829360 ↗
21. 10.1179/1433075X13Y.000000008410.1179/1433075X13Y.0000000084 ↗
22. 10.1021/bm060334210.1021/bm0603342 ↗
23. 10.1016/S0142-9612(02)00549-510.1016/S0142-9612(02)00549-5 ↗
24. 10.1016/j.biomaterials.2004.03.01310.1016/j.biomaterials.2004.03.013 ↗
25. 10.1002/jbm.a.3109510.1002/jbm.a.31095 ↗
26. 10.1080/00914037.2012.66421310.1080/00914037.2012.664213 ↗
27. ISO 10993-4. Selection of tests for interaction with blood. International Standard Organization: Geneva, Switzerland, 1992.